Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus

Fig. 1

Serum anti-high mobility box protein-1 (HMGB1) antibody levels determined by ELISA. a The average level of anti-HMGB1 was significantly higher in the systemic lupus erythematosus (SLE) patients (median 132.5 arbitrary units (AU)) compared to the healthy controls (median 81 AU). Dashed line indicates the cut-off level for a positive test. Solid lines represent median values. Note the axis break. b Serum levels in SLE patients categorised into renal non-active, renal active (see text for definitions), non-renal active with systemic lupus erythematosus disease activity index (SLEDAI)-2K ≤4, and non-renal active with SLEDAI-2K >4

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us